Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Familial hypercholesterolemia: Underdiagnosed, risks underappreciated; new treatments on horizon Erik Swain
• Spot the difference: LV trabeculation vs. LV noncompaction Filip Zemrak, MD; Steffen E. Petersen, MD, DPhil, MPH, FESC
• FDA approves DCB to treat PAD in upper leg
• FDA approves edoxaban to reduce stroke risk, treat DVT and PE
• FDA approves fixed-dose combination for patients with hypertension
• FDA clears test that helps predict risk for CHD
• BP drugs reduced risk for CV events, death in patients with mild hypertension
• Carotid artery stenting may be risky for older adults
• Childhood obesity affected cardiac geometry, function
• Collaborative, community-based hypertension program improved BP control
• Daily avocado consumption improved LDL cholesterol
• Digoxin linked to elevated risk for death, hospitalization in patients with AF
• Long-term studies reveal major improvements in outcomes after pediatric cardiac surgery
• Outcomes of hospitalized cardiac patients OK when physicians away at cardiology conferences
• Newer ICD leads associated with low rates of mechanical failure
• No difference in outcome between remote robotic navigation, manual ablation for AF
• Nonsmokers hospitalized for CHD rarely screened for secondhand smoke
• Physician counseling on sexual activity uncommon after acute MI
• Potential TAVR risks understated on hospital websites
• Price increases for CABG, PCI slowed after advent of public reporting on quality
• Q-SYMBIO: Coenzyme Q10 reduced major CV events in patients with HF
• Rate of inappropriate aspirin use for primary CVD prevention may exceed 10%
• Stressful duties increased sudden cardiac death risk for police officers
• Survival rates higher in obese patients with HF
• US hospitals lack optimal reperfusion strategies for STEMI patients
• USPSTF: Ambulatory BP should be used to confirm elevated office BP
• Whole-grain consumption associated with lower total, CVD mortality
• MR CLEAN: Intra-arterial therapy safe, effective for certain acute ischemic strokes
• Third-generation transcatheter heart valve improves on deficiencies of earlier valves
• Interventional cardiology recognized as separate specialty by CMS
• Ticagrelor met primary endpoint in PEGASUS-TIMI 54 trial
• Bruce L. Wilkoff, MD, reflects on a career of improving pacemakers, defibrillators
• Addition of mitral valve repair to CABG showed no benefit in ischemic mitral regurgitation
• CONTROL-HTN: Mechanical device improved BP in patients with resistant arterial hypertension
• Early PCI encouraged after out-of-hospital cardiac arrest in certain patients
• Long-term overtreatment with warfarin raised risk for dementia
• Myocardial ischemia common in young women with CHD under mental stress
• Physical activity program did not prevent CV events in older adults
• Taking first suitable heart may benefit cost, survival in children needing transplantation
• TOPCAT: Spironolactone effectiveness differed by region
• Strategies to overcome diuretic resistance in congestive HF Bryan Robinette, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: ANNEXA-A
• Trial Scorecard: ATHEROREMO-NIRS
• Trial Scorecard: ATRIA-CVRN
• Trial Scorecard: CONCORD
• Trial Scorecard: MR CLEAN
• Trial Scorecard: OPTION
• Trial Scorecard: Q-SYMBIO
• Trial Scorecard: VIRGO